E2F1 and hepatocellular carcinoma: In another study, miR-429 functioned by manipulating liver tumor-initiating cells to target the RBBP4/E2F1/OCT4 axis and was upregulated in HCC due to four aberrant hypomethylated upstream sites (Li L. et al., 2015).